Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 201-210 of 229 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Analysis of KRAS/NRAS mutations in a phase III study of panitumumab with FOLFIRI compared with FOLFIRI zlone as second-line treatment for metastatic colorectal cancerPeeters, M.; Oliner, K.; Price, T.; Cervantes, A.; Sobrero, A.; Ducreux, M.; Hotko, Y.; André, T.; Chan, E.; Lordick, F.; Punt, C.; Strickland, A.; Wilson, G.; Ciuleanu, T.; Roman, L.; Van Cutsem, E.; He, P.; Yu, H.; Koukakis, R.; Terwey, J.; et al.
2012Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010Vos, T.; Flaxman, A.; Naghavi, M.; Lozano, R.; Michaud, C.; Ezzati, M.; Shibuya, K.; Salomon, J.; Abdalla, S.; Aboyans, V.; Abraham, J.; Ackerman, I.; Aggarwal, R.; Ahn, S.; Ali, M.; Alvarado, M.; Anderson, H.; Anderson, L.; Andrews, K.; Atkinson, C.; et al.
2013A no-prophylaxis platelet-transfusion strategy for hematologic cancersStanworth, S.; Estcourt, L.; Powter, G.; Kahan, B.; Dyer, C.; Choo, L.; Bakrania, L.; Llewelyn, C.; Littlewood, T.; Soutar, R.; Norfolk, D.; Copplestone, A.; Smith, N.; Kerr, P.; Jones, G.; Raj, K.; Westerman, D.; Szer, J.; Jackson, N.; Bardy, P.; et al.
2017Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)McElvaney, N.; Burdon, J.; Holmes, M.; Glanville, A.; Wark, P.; Thompson, P.; Hernandez, P.; Chlumsky, J.; Teschler, H.; Ficker, J.; Seersholm, N.; Altraja, A.; Mäkitaro, R.; Chorostowska-Wynimko, J.; Sanak, M.; Stoicescu, P.; Piitulainen, E.; Vit, O.; Wencker, M.; Tortorici, M.; et al.
2013Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney diseaseDe Zeeuw, D.; Akizawa, T.; Audhya, P.; Bakris, G.; Chin, M.; Christ-Schmidt, H.; Goldsberry, A.; Houser, M.; Krauth, M.; Lambers Heerspink, H.; McMurray, J.; Meyer, C.; Parving, H.; Remuzzi, G.; Toto, R.; Vaziri, N.; Wanner, C.; Wittes, J.; Wrolstad, D.; Chertow, G.; et al.
2017Docosahexaenoic acid and bronchopulmonary dysplasia in preterm infantsCollins, C.; Makrides, M.; McPhee, A.; Sullivan, T.; Davis, P.; Thio, M.; Simmer, K.; Rajadurai, V.; Travadi, J.; Berry, M.; Liley, H.; Opie, G.; Tan, K.; Lui, K.; Morris, S.; Stack, J.; Stark, M.; Chua, M.; Jayagobi, P.; Holberton, J.; et al.
2020Five insights from the Global Burden of Disease Study 2019Murray, C.J.L.; Abbafati, C.; Abbas, K.M.; Abbasi, M.; Abbasi-Kangevari, M.; Abd-Allah, F.; Abdollahi, M.; Abedi, P.; Abedi, A.; Abolhassani, H.; Aboyans, V.; Abreu, L.G.; Abrigo, M.R.M.; Abu-Gharbieh, E.; Abu Haimed, A.K.; Abushouk, A.I.; Acebedo, A.; Ackerman, I.N.; Adabi, M.; Adamu, A.A.; et al.
2018Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk diseaseBranford, S.; Wang, P.; Yeung, D.T.; Thomson, D.; Purins, A.; Wadham, C.; Shahrin, N.H.; Marum, J.E.; Nataren, N.; Parker, W.T.; Geoghegan, J.; Feng, J.; Shanmuganathan, N.; Mueller, M.C.; Dietz, C.; Stangl, D.; Donaldson, Z.; Altamura, H.; Georgievski, J.; Braley, J.; et al.
2017Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biasesStessman, H.; Xiong, B.; Coe, B.; Wang, T.; Hoekzema, K.; Fenckova, M.; Kvarnung, M.; Gerdts, J.; Trinh, S.; Cosemans, N.; Vives, L.; Lin, J.; Turner, T.; Santen, G.; Ruivenkamp, C.; Kriek, M.; Van Haeringen, A.; Aten, E.; Friend, K.; Liebelt, J.; et al.
2018Pathogenic variants in E3 ubiquitin ligase RLIM/RNF12 lead to a syndromic X-linked intellectual disability and behavior disorderFrints, S.G.M.; Ozanturk, A.; Rodríguez Criado, G.; Grasshoff, U.; de Hoon, B.; Field, M.; Manouvrier-Hanu, S.; E Hickey, S.; Kammoun, M.; Gripp, K.W.; Bauer, C.; Schroeder, C.; Toutain, A.; Mihalic Mosher, T.; Kelly, B.J.; White, P.; Dufke, A.; Rentmeester, E.; Moon, S.; Koboldt, D.C.; et al.